| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0140-6736(99)02001-2 |
| P698 | PubMed publication ID | 10359415 |
| P2093 | author name string | R Piarroux | |
| L Millon | |||
| H Koenig | |||
| O Vagner | |||
| K Bardonnet | |||
| P2860 | cites work | Saccharomyces boulardii'. A Review of an Innovative Biotherapeutic Agent | Q29013282 |
| The identification of pathogenic yeast strains by electrophoretic analysis of their chromosomes | Q68518189 | ||
| PCR amplification of the rDNA internal transcribed spacer region for differentiation of Saccharomyces cultures | Q71982457 | ||
| Fungemia with Saccharomyces cerevisiae after treatment with Saccharomyces boulardii | Q74830380 | ||
| P433 | issue | 9167 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1851-1852 | |
| P577 | publication date | 1999-05-01 | |
| P1433 | published in | The Lancet | Q939416 |
| P1476 | title | Are live saccharomyces yeasts harmful to patients? | |
| P478 | volume | 353 |
| Q34808457 | A Saccharomyces cerevisiae mutant with increased virulence. |
| Q90129566 | Baker's Yeast Clinical Isolates Provide a Model for How Pathogenic Yeasts Adapt to Stress |
| Q37836193 | Cell Signals, Cell Contacts, and the Organization of Yeast Communities |
| Q58617893 | Control of nongenetic heterogeneity in growth rate and stress tolerance of Saccharomyces cerevisiae by cyclic AMP-regulated transcription factors |
| Q34767527 | Current and future treatment modalities for Clostridium difficile-associated disease |
| Q46782350 | Determination of MICING: a new assay for assessing minimal inhibitory concentration for invasive growth |
| Q21128674 | Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland |
| Q33971185 | Microsatellite typing as a new tool for identification of Saccharomyces cerevisiae strains |
| Q35578814 | Outbreak of Saccharomyces cerevisiae Subtype boulardii Fungemia in Patients Neighboring Those Treated with a Probiotic Preparation of the Organism |
| Q41997023 | Probiotic Properties of Lyophilized Cell Free Extract of Lactobacillus casei |
| Q34820549 | Probiotics and non-intestinal infectious conditions |
| Q42470900 | Probiotics for pediatric antibiotic-associated diarrhea: a meta-analysis of randomized placebo-controlled trials |
| Q24186991 | Probiotics for the prevention of pediatric antibiotic-associated diarrhea |
| Q24235039 | Probiotics for the prevention of pediatric antibiotic-associated diarrhea |
| Q24245196 | Probiotics for the prevention of pediatric antibiotic-associated diarrhea |
| Q24247364 | Probiotics for the prevention of pediatric antibiotic-associated diarrhea |
| Q91644124 | Probiotics for the prevention of pediatric antibiotic-associated diarrhea |
| Q24236704 | Probiotics for treating acute infectious diarrhoea |
| Q24247695 | Probiotics for treating infectious diarrhoea |
| Q28087466 | Risk and safety of probiotics |
| Q35863469 | Saccharomyces boulardii fungemia caused by treatment with a probioticum |
| Q55313368 | Synergistic and antagonistic effects of immunomodulatory drugs on the action of antifungals against Candida glabrata and Saccharomyces cerevisiae. |
| Q30048623 | The inositol regulon controls viability in Candida glabrata |
| Q24522336 | Typing of Saccharomyces cerevisiae clinical strains by using microsatellite sequence polymorphism |
| Q37163002 | Whole Genome Analysis of 132 Clinical Saccharomyces cerevisiae Strains Reveals Extensive Ploidy Variation |
| Q33724336 | Wickerhamomyces anomalus in the sourdough microbial ecosystem |
Search more.